BOTHELL, Wash., Dec. 12 /PRNewswire-FirstCall/ -- Cardiac Science Corporation , a global leader in advanced cardiac monitoring and defibrillation products, today announced that it has successfully completed the first implementation of its Pyramis ECG Data Management System under the terms of a global value-added reseller (VAR) agreement with Cerner Corporation .
(Photo: http://www.newscom.com/cgi-bin/prnh/20050913/SFTU139LOGO )
The recently completed installation for Minot, North Dakota-based Trinity Health provides an integrated and electronic healthcare information system solution that will seamlessly combine Cardiac Science Corp.'s Pyramis ECG Data Management System within Cerner’s comprehensive hospital information system architecture.
“This successful implementation represents a significant milestone in our long-term efforts to offer advanced cardiology data management solutions to a broader client base of hospitals and physician offices,” said John Hinson, chief executive officer of Cardiac Science Corporation.
“Our Pyramis solution provides clients with a scalable and high-quality cardiology information management system that is easy to use, learn and support,” continued Hinson. “By leveraging our strategic VAR agreement with Cerner, we are now in a stronger position to maximize new sales avenues for our ECG products and services.”
“Our decision to move forward with Pyramis is based largely on its seamless integration capabilities with Cerner’s information system, which we anticipate will provide an efficient, flexible and user-friendly solution best suited to our evolving needs,” said Mark Waldera, director of therapy services at Trinity Health. “Successfully implementing the Pyramis solution represents a critical step for us as we transition towards a fully integrated electronic medical records system at Trinity Health.”
While many health care organizations typically process and collect vast amounts of patient information generated from disparate sources in hard-copy format, the healthcare industry is increasingly moving towards implementing electronic-based information systems to more efficiently integrate and manage all of the interrelated data.
Cardiac Science Corp.'s Pyramis ECG Data Management System centralizes diagnostic ECG data to provide instant electronic access to this information at any time or from any location. By automating and streamlining the storage, editing, retrieval and sharing of patient cardiology data including resting ECGs, stress tests, Holter tests, and 12-lead ECGs from bedside monitors, Pyramis helps increase workplace productivity and efficiency within hospitals and physician offices to provide enhanced patient care.
The global VAR agreement was originally signed with Cerner Corporation by Quinton Cardiology Systems, a predecessor company to Cardiac Science Corporation, in November 2004.
About Cardiac Science Corporation
Cardiac Science Corporation develops, manufactures, and markets a family of advanced diagnostic and therapeutic cardiology devices and systems, including automated external defibrillators, electrocardiographs, stress test systems, Holter monitoring systems, hospital defibrillators, cardiac rehabilitation telemetry systems, patient monitor -- defibrillators and cardiology data management systems. Cardiac Science Corporation also sells a variety of related products and consumables, and provides a comprehensive portfolio of training, maintenance and support services.
The company is the successor to various entities that have owned and operated cardiology related businesses, which sold products under the trusted brand names Burdick(R), Powerheart(R), and Quinton(R). Cardiac Science Corporation is headquartered in Bothell, WA, and also has operations in Lake Forest, California; Deerfield, Wisconsin; Shanghai, China; Copenhagen, Denmark and Manchester, United Kingdom.
Forward Looking Statements
This press release contains forward-looking statements, including, but not limited to, those relating to Cardiac Science Corporation’s future revenue growth and profitability that involve a number of risks and uncertainties. These are forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. The words “believe,” “expect,” “intend,” anticipate,” variations of such words, and similar expressions identify forward-looking statements, but their absence does not mean that the statement is not forward-looking. Actual results may vary significantly from the results expressed or implied in such statements. Factors that could cause or contribute to such varying results and other risks are more fully described in the registration statement on Form S-4/A that was filed by Cardiac Science Corporation under the name CSQ Holding Company on July 28, 2005, under the caption “Risk Factors,” and in the Annual Reports of Quinton Cardiology Systems, Inc. and Cardiac Science, Inc. on Form 10-K for the year ended December 31, 2004, under the captions “Certain Factors that May Affect Future Results” and in other documents, we file with the Securities and Exchange Commission. Cardiac Science Corporation undertakes no duty or obligation to update the information provided herein.
CONTACT: Mike Matysik, Sr. Vice President and CFO of Cardiac Science Corp., +1-425-402-2009; or Lora Lee of The Fearey Group, +1-206-343-1543, for Cardiac Science Corp.
Photo: http://www.newscom.com/cgi-bin/prnh/20050913/SFTU139LOGOAP Archive: http://photoarchive.ap.orgPRN Photo Desk photodesk@prnewswire.comCardiac Science Corporation
CONTACT: Mike Matysik, Sr. Vice President and CFO of Cardiac ScienceCorp., +1-425-402-2009; or Lora Lee of The Fearey Group, +1-206-343-1543,for Cardiac Science Corp.
Web site: http://www.cardiacscience.com//
